Patient Guide: MATERIALS FOR IMMUNE-ONCOLOGY TRIALS: MEN2501-01 (PHASE 1/2) — A PHASE 1/2 STUDY OF MEN2501, A KIF18A INHIBITOR, IN PARTICIPANTS WITH OVARIAN CANCER

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at multiple participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTMEN2501-01
Status: 🟢 Enrolling Now
Condition: Ovarian cancer
Phase: PHASE1, PHASE2

Loading interactive enrollment tools...

The full interactive experience will load momentarily